Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D

Journal of the American Association for Laboratory Animal Science

Volumn 49, Issue 3, 2010, Pages 294-299

  Martino Cardona, Maria Del Carmen ^a   Beck, Sarah E ^a   Brayton, Cory ^a   Watson, Julie ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SHEDDING; BODY WEIGHT; CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; FIBROSIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD1; CLARITHROMYCIN; COMPLEMENT FACTOR D; DRUG COMBINATIONS; FEMALE; HELICOBACTER; HELICOBACTER INFECTIONS; IMMUNOCOMPROMISED HOST; MALE; METRONIDAZOLE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OMEPRAZOLE; RODENT DISEASES;

ANIMALIA; HELICOBACTER; HELICOBACTER BILIS; HELICOBACTER HEPATICUS; HELICOBACTER RODENTIUM; MUS; RODENTIA;

EID: 77953190704     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. tm1Mak mice. Contemp Top Lab Anim Sci 39:39-41.
2. Artwohl JE, Purcell JE, Fortman JD. 2008. The use of cross-foster rederivation to eliminate murine norovirus, Helicobacter spp., and murine hepatitis virus from a mouse colony. J Am Assoc Lab Anim Sci 47:19-24.
3. Beckwith CS, Franklin CL, Hook RR Jr, Besch-Williford CL, Riley LK. 1997. Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents. J Clin Microbiol 35:1620-1623. (Pubitemid 27216851)
4. Clifford CB, Walton BJ, Reed TH, Coyle MB, White WJ, Amyx HL. 1995. Hyperkeratosis in athymic nude mice caused by a coryneform bacterium: microbiology, transmission, clinical signs, and pathology. Lab Anim Sci 45:131-139.
5. Crisler-Roberts R, Ge Z, Kearney MT, Singletary KB, Fox JG, Roberts CS, Baker DG. 2005. Evaluation of Helicobacter hepaticus bacterial shedding in fostered and sex-segregated C57BL mice. Comp Med 55:515-522.
6. Chichlowski M, Hale LP. 2009. Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies. Comp Med 59:10-17.
7. Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP. 2008. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. Comp Med 58:534-541.
8. Chin EY, Dangler CA, Fox JG, Schauer DB. 2000. Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor αβ mutant mice. Comp Med 50:586-594.
9. Foltz CJ, Fox JG, Yan L, Shames B. 1995. Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus. Antimicrob Agents Chemother 39:1292-1294.
10. Foltz CJ, Fox JG, Yan L, Shames B. 1996. Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus. Lab Anim Sci 46:193-197. (Pubitemid 126482104)
11. Fox JG, Rogers AB, Whary MT, Taylor NS, Xu S, Feng Y, Keys S. 2004. Helicobacter bilis-associated hepatitis in outbred mice. Comp Med 54:571-577. (Pubitemid 39557452)
12. Franklin CL. 2006. Microbial considerations in genetically engineered mouse research. ILAR J 47:141-155.
13. Froberg-Fejko KM. 2008. Personal communication.
14. Goto K, Ohashi H, Takakura A, Itoh T. 2000. Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan. Curr Microbiol 41:161-166.
15. Hailey JR, Haseman JK, Bucher JR, Radovsky AE, Malarkey DE, Miller RT, Nyska A, Maronpot RR. 1998. Impact of Helicobacter hepaticus infection in B6C3F1 mice from 12 National Toxicology Program 2-year carcinogenesis studies. Toxicol Pathol 26:602-611. (Pubitemid 28462711)
16. Institute of Laboratory Animal Resources. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
17. Jury J, Gee LC, Delaney KH, Perdue MH, Bonner RA. 2005. Eradication of Helicobacter spp. from a rat breeding colony. Contemp Top Lab Anim Sci 44:8-11. (Pubitemid 41040560)
18. Kerton A, Warden P. 2006. Review of successful treatment for Helicobacter species in laboratory mice. Lab Anim 40:115-122.
19. Kostomitsopoulos N, Donnelly H, Kostavasili I, Paronis E, Alexakos P, Karayannacos P. 2007. Eradication of Helicobacter bilis and H. hepaticus from infected mice by using a medicated diet. Lab Anim (NY) 36:37-40.
20. Macy JD Jr, Weir EC, Compton SR, Shlomchik MJ, Brownstein DG. 2000. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B-cell-deficient mice: diagnosis and therapy. Comp Med 50:49-55.
21. Matysiak-Budnik T, van Niel G, Megraud F, Mayo K, Bevilacqua C, Gaboriau-Routhiau V, Moreau MC, Heyman M. 2003. Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice. Infect Immun 71:5219-5224. (Pubitemid 37070767)
22. O'Keeffe J, Moran AP. 2008. Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter 13:1-19.
23. Percy DH, Barta JR. 1993. Spontaneous and experimental infections in SCID and SCID-Beige mice. Lab Anim Sci 43:127-132. (Pubitemid 23358314)
24. Percy DH, Barthold SW. 2007. Pathology of laboratory rodents and rabbits, 3rd ed, p 50-82. Ames (IA): Wiley-Blackwell.
25. Pritchett-Corning KR, Cosentino J, Clifford CB. 2009. Contemporary prevalence of infectious agents in laboratory mice and rats. Lab Anim 43:165-173.
26. Russell RJ, Haines DC, Anver MR, Battles JK, Gorelick PL, Blumenauer LL, Gonda MA, Ward JM. 1995. Use of antibiotics to prevent hepatitis and typhlitis in male SCID mice spontaneously infected with Helicobacter hepaticus. Lab Anim Sci 45:373-378.
27. Savage DC, Dubos R. 1968. Alterations in the mouse cecum and its flora produced by antibacterial drugs. J Exp Med 128:97-110.
28. Savage DC, McAllister JS. 1971. Cecal enlargement and microbial flora in suckling mice given antibacterial drugs. Infect Immun 3:342-349.
29. Scanziani E, Gobbi A, Crippa L, Giusti AM, Pesenti E, Cavalletti E, Luini M. 1998. Hyperkeratosis-associated coryneform infection in severe combined immunodeficient mice. Lab Anim 32:330-336.
30. Scavizzi F, Raspa M. 2006. Helicobacter typhlonius was detected in the sex organs of 3 mouse strains but did not transmit vertically. Lab Anim 40:70-79. (Pubitemid 43341086)
31. Sharp JM, Vanderford DA, Chichlowski M, Myles MH, Hale LP. 2008. Helicobacter infection decreases reproductive performance of IL10-deficient mice. Comp Med 58:447-453.
32. Shomer NH, Dangler CA, Marini RP, Fox JG. 1998. Helicobacter bilis-Helicobacter rodentium coinfection associated with diarrhea in a colony of SCID mice. Lab Anim Sci 48:455-459. (Pubitemid 28531352)
33. Singletary KB, Kloster CA, Baker DG. 2003. Optimal age at fostering for derivation of Helicobacter hepaticus-free mice. Comp Med 53:259-264.
34. Skold M, Behar SM. 2003. Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun 71:5447-5455. (Pubitemid 37205594)
35. Taylor NS, Xu S, Nambiar P, Dewhirst FE, Fox JG. 2007. Enterohepatic Helicobacter spedes are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J Clin Microbiol 45:2166-2172.
36. Truett GE, Walker JA, Baker DG. 2000. Eradication of infection with Helicobacter spp. by use of neonatal transfer. Comp Med 50:444-451.
37. Tupin E, Kinjo Y, Kronenberg M. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5:405-417.
38. Van Keuren ML, Saunders TL. 2004. Rederivation of transgenic and gene-targeted mice by embryo transfer. Transgenic Res 13:363-371.
39. Ward JM, Anver MR, Haines DC, Melhorn JM, Gorelick P, Yan L, Fox JG. 1996. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci 46:15-20.
40. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, Tully JG, Russell RJ, Benvensite RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, Rice JM . 1994. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86:1222-1227.
41. Watson J, Thompson KN, Feldman SH. 2005. Successful rederivation of contaminated immunocompetent mice using neonatal transfer with iodine immersion. Comp Med 55:465-469.
42. Whary MT, Fox JG. 2006. Detection, eradication, and research implications of Helicobacter infections in laboratory rodents. Lab Anim (NY) 35:25-27, 30-36.
43. Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE. 2001. Complement activation in factor D-deficient mice. Proc Natl Acad Sci USA 98:14577-14582.